Thus, elevated levels of heparanase may activate syndecan family members and promote tumor metastasis and angiogenesis, resulting in poor prognosis often associated with patients exhibiting high levels of heparanase [22], [25]. This evidence concerns the gene SDC1 and neoplasm.